Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Akili, Inc. - Common Stock (NQ: AKLI )

0.2480 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.2480
Bid (Size) 0.2223 (12)
Ask (Size) 0.2629 (1)
Prev. Close 0.2480
Today's Range 0.2480 - 0.2480
52wk Range 0.1912 - 1.670
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga

Performance

YTD
-48.08%
-48.08%
1 Month
-15.62%
-15.62%
3 Month
-11.43%
-11.43%
6 Month
-49.47%
-49.47%
1 Year
-76.38%
-76.38%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For February 29, 2024
Via Benzinga
Preview: Akili's Earnings
Via Benzinga
Why Is Akili (AKLI) Stock Up 110% Today?
Via InvestorPlace
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From Akili, Inc.
Via Business Wire
PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan
From PureTech Health plc
Via Business Wire
Gold Moves Lower; Pilgrim's Pride Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Crude Oil Gains 1%; US New Home Sales Increase In January
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Is Prescription Digital Medicine-Focused Akili Stock Trading Over 100% On Monday?
Via Benzinga
US Stocks Edge Higher; Domino's Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan
From Akili, Inc.
Via Business Wire
Akili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance Updates
From Akili, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
EndeavorRxⓇ, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17
From Akili, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.